Medication safety for children with medical complexity

Kathleen Huth1, Patricia Vandecruys1, Julia Orkin1

  • 1Canadian Paediatric Society, Community Paediatrics Committee, Ottawa, Ontario.

Paediatrics & Child Health
|November 12, 2020
PubMed

Insights

Children with medical complexity (CMC) face higher medication error risks due to complex care needs. This guidance offers practical strategies to improve medication safety for CMC in various healthcare settings.

Area of Science:

  • Pediatric Healthcare
  • Patient Safety
  • Health Technology

Background:

  • Advances in medical care and health technology enable longer lifespans for children with life-limiting conditions.
  • Children with medical complexity (CMC) have chronic conditions, high healthcare utilization, and technology dependence.
  • CMC are at increased risk for medication errors due to care complexity and fragility.

Purpose of the Study:

  • To provide clinical guidance for healthcare professionals on medication safety for CMC.
  • To address the lack of data on factors contributing to medication errors in CMC.
  • To offer practical strategies for improving medication safety in both outpatient and inpatient settings for CMC.

Main Methods:

  • Literature review on medication safety in CMC.
  • Analysis of factors contributing to medication errors in this population.
  • Development of evidence-based clinical practice recommendations.

Main Results:

  • Identified high rates of care fragmentation, miscommunication, and polypharmacy in CMC.
  • Highlighted increased opportunities for medication errors during care transitions.
  • Emphasized the need for targeted interventions to mitigate risks.

Conclusions:

  • Medication safety for CMC requires focused attention and tailored strategies.
  • Addressing care fragmentation and improving communication are crucial for error prevention.
  • Implementing practical guidance can enhance medication safety for CMC, improving patient outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
120
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
120
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
128
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
97
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
144